Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
BioNTech signs deal to co-develop OncoC4's cancer drug
Reuters
Tue, 03/21/23 - 10:05 am
BioNTech
OncoC4
cancer
oncology
drug development
ONC-392
Keytruda Unlocked: How Should Merck Proceed with Trials?
BioSpace
Tue, 03/14/23 - 11:19 am
Keytruda
Merck
cancer
clinical trials
FDA pauses Mersana’s clinical trial after patient dies
Endpoints
Mon, 03/13/23 - 10:54 am
Mersana
clinical trials
FDA
patient death
cancer
XMT-2056
antibody-drug conjugate
The state of the oncology microbiome therapeutics pipeline at a glance
Clinical Trials Arena
Fri, 03/10/23 - 11:23 am
oncology
cancer
microbiome
drug development
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine
BioSpace
Tue, 03/7/23 - 10:21 pm
Moderna Therapeutics
MRNA
vaccines
cancer
cancer vaccines
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Fierce Biotech
Tue, 03/7/23 - 11:45 am
Volastra Therapeutics
Eli Lilly
funding
sovilnesib
Amgen
cancer
Tempus, Pfizer partner for cancer drug development
Pharmaceutical Business Review
Wed, 03/1/23 - 09:46 am
Pfizer
Tempus
cancer
drug development
artificial intelligence
machine learning
Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody
Fierce Biotech
Tue, 02/28/23 - 09:56 am
cancer
Biocytogen
Chipscreen NewWay Biosciences
Merck
Keytruda
YH008
Roche and Blueprint agree to end collaboration for cancer drug Gavreto
Endpoints
Thu, 02/23/23 - 04:30 pm
Roche
Gavreto
Blueprint Medicines
cancer
BioNTech touts differences with Moderna in race for cancer vaccines
Endpoints
Tue, 02/21/23 - 04:41 pm
BioNTech
Moderna Therapeutics
Merck
vaccines
cancer
cancer vaccines
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Pharmaceutical Business Review
Fri, 02/17/23 - 09:44 am
Fresenius Kabi
Stimufend
pegfilgrastim
biosimilars
Neulasta
Amgen
cancer
GSK was warned repeatedly about Zantac impurity but played down risks
Fierce Pharma
Wed, 02/15/23 - 06:09 pm
GSK
Zantac
FDA
cancer
In State of the Union, Biden highlights drug prices, cancer, and affordable care
Chief Healthcare Executive
Wed, 02/8/23 - 11:01 am
Joe Biden
drug pricing
healthcare reform
cancer
Oncolytic virus startup TILT raises €22M to advance cancer therapies
Endpoints
Tue, 02/7/23 - 11:05 am
TILT Biotherapeutics
oncolytic viruses
clinical trials
cancer
oncology
Grey Wolf Therapeutics Closes Oversubscribed $49 Million Series B Financing to Advance First-of-its-Kind Neoantigen Creation Approaches
PR Newswire
Thu, 01/26/23 - 10:44 am
Grey Wolf Therapeutics
cancer
funding
neoantigens
Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo
Fierce Pharma
Tue, 01/24/23 - 06:31 pm
Bristol Myers Squibb
legal
AstraZeneca
Imjudo
Yervoy
cancer
patents
Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio
BioSpace
Sun, 01/22/23 - 01:09 pm
Regen Biopharma
exosomes
cancer
drug development
Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is
Stat
Sun, 01/22/23 - 01:05 pm
cancer
oncology
mesothelin
solid tumors
FDA details approach for finding optimal dosages for new cancer drugs
RAPS.org
Wed, 01/18/23 - 10:42 am
FDA
oncology
cancer
regulatory
Moderna’s experimental cancer vaccine treats but doesn’t prevent melanoma – a biochemist explains how it works
The Conversation
Wed, 01/18/23 - 09:44 am
Moderna Therapeutics
vaccines
cancer
melanoma
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »